Neurodon CEO Dr. Russell Dahl to Present at the 20th FASEB Conference on Calcium and Cell Function
Neurodon Corp., a leader in the development of therapeutics targeting calcium homeostasis, is proud to announce that its CEO, Russell Dahl, Ph.D., will present at the 20th FASEB Conference on Calcium and Cell Function held in Winnipeg, Canada on July 6 – 10, 2025. Since 1987, this conference has been the eminent platform to present […]